New and innovative devices from aneurysms to radial access - one-year Experience with the Pipeline™ Vantage with Shield Technology™ and early results using the Rist™ device

From LINNC Paris 2022, join Dr Saleh Lamin as he discusses with Dr Riitta Rautio about the Pipeline™ Vantage with Shield Technology™ and early experience in 100 patients using the Rist™ device for radial access.

 

With the introduction of the 0.021” system with longer catheters and implant diameters – previously not available for the Pipeline™ Shield – the Pipeline™ Vantage with the proven Shield Technology™ offers performance enhancements that increase reliability with improved visibility, easier opening and trackability, and with good occlusion results. What does the Pipeline™ Vantage offer for your interventions? For Dr Rautio the answer is clear, the compatibility with 0.021 means safer access more distally than ever before when treating aneurysms.

 

And introducing Rist™ – an innovative radial access device that your patients – and cath lab staff – will be asking for! Find out why, as Dr Rautio presents her initial experience in this revealing discussion…

INTERVIEW

Efficacy of Onyx™ embolization for the endovascular management of cerebral arteriovenous malformations

INTERVIEW

New Technologies for Stroke Treatment

READ & SHARE TOPIC

Right-sided paraophthalmic aneurysm treated with a Pipeline™ Vantage Shield using RIST™ Radial access System

READ & SHARE TOPIC

New Pipeline™ Vantage with Shield technology treatment with RIST™ radial system

INTERVIEW

Medtronic: Leading the way to the future with devices you need through continued research, development and clinical expertise